Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G5TU
|
||||
Former ID |
DIB003749
|
||||
Drug Name |
LESOPITRON DIHYDROCHLORIDE
|
||||
Synonyms |
Lesopitran; Lesopitran); E-4424; Lesopitron dihydrochloride < Rec INNM >; 2-[4-[4-(4-Chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine dihydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Mood disorder [ICD10:F30-F39] | Discontinued in Phase 2 | [1] | ||
Company |
Esteve Group
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H21ClN6
|
||||
Canonical SMILES |
C1CN(CCN1CCCCN2C=C(C=N2)Cl)C3=NC=CC=N3
|
||||
InChI |
1S/C15H21ClN6/c16-14-12-19-22(13-14)7-2-1-6-20-8-10-21(11-9-20)15-17-4-3-5-18-15/h3-5,12-13H,1-2,6-11H2
|
||||
InChIKey |
AHCPKWJUALHOPH-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 132449-46-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | Agonist | [2] | |
KEGG Pathway | cAMP signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Serotonergic synapse | |||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT1 type receptor mediated signaling pathway | |||||
Reactome | Serotonin receptors | ||||
G alpha (i) signalling events | |||||
WikiPathways | Serotonin HTR1 Group and FOS Pathway | ||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001441) | ||||
REF 2 | Effect of acute administration of the 5-HT1A receptor ligand, lesopitron, on rat cortical 5-HT and dopamine turnover. Br J Pharmacol. 1994 Oct;113(2):425-30. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.